MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFR therapeutics


Aksoy S., Kanat O., Tunca B. , Ertas H., Ugras N., Ozturk E., ...More

International Congress on Targeted Anticancer Therapies (TAT), Paris, France, 5 - 07 March 2018, vol.29 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 29
  • City: Paris
  • Country: France